Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: NeuraLight.
- Who it may be relevant to
- Registry conditions: Eye Movement. Basic parameters: 18 years — 90 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.
Detailed description
The purpose of the trial is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants, and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system. In addition, we also aim to collect oculometric data from healthy participants in order to optimize a regression model which can be used for future prediction of clinical endpoints in various neurological patients at different stages of disease
Interventions
- Other NeuraLight
NeuraLight is an investigational software-based platform used for measuring eye movements in response to visual stimuli and captured using a simple webcam
Primary outcome measures
- Efficacy of data capture [Time frame: 36 months]
- Validation of data capture [Time frame: 36 months]
Secondary outcome measures (1)
- Optimization of data capture [Time frame: 36 months]
Eligibility criteria
Inclusion criteria
- Men and women ages between 18 and 90 years old
- Normal or corrected vision
- Ability to follow instructions
- Willing and able to sign an informed consent form
Exclusion criteria
- Inability to sit for 20 minutes on a chair in a calm manner
- Personal or 1st degree relative history of epilepsy
- Additional neurological diseases
- Drug or alcohol abuse
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- NeuraLight — Wilmington
Identifiers
NCT: NCT05476523 · HDC/2022-3